Skip to content

Cryptosporidium Species in Sohag Governorate

Genetic Diversity of Cryptosporidium Species Infecting Human in Sohag Governorate

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05208970
Enrollment
200
Registered
2022-01-26
Start date
2022-03-01
Completion date
2025-01-31
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cryptosporidiosis

Brief summary

Cryptosporidium species are increasingly recognized as important enteric pathogens that infect a broad range of hosts including human, domestic and wild animals worldwide, causing asymptomatic or mild-to-severe gastrointestinal disease in their host species. There are 38 species of Cryptosporidium that have been described, going from amphibian parasites to mammals ones, with over 40 genotypes infecting mammals, although Cryptosporidium parvum and Cryptosporidium hominis are the two species predominantly reported in human infections. In Cairo and Sharkyia governorates in Egypt, Cryptosporidium is a common intestinal parasite among children, especially in diarrheic, preschool-aged children, with a predominance of C. hominis indicates anthroponotic rather than zoonotic transmission. Also in the sohag governorate, Cryptosporidium infection is a common intestinal parasite, as in the last five years its prevalence about 35% but there is no study clarify predominant genotype of Cryptosporidium in sohag.

Interventions

None listed

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. Age: any age 2. Sex: male -female 3. Residence: rural-urban 4. Animal contact. 5. Immune status: immunocompetent - immunocompromised 6. Clinical manifestations: diarrhea -abdominal pain- fever- vomiting.

Exclusion criteria

* patients taking treatment for cryptosporidiosis

Design outcomes

Primary

MeasureTime frame
estimate the prevalence and clarify the species and genotypes/subtypes of Cryptosporidium spp. in sohag.24 weeks

Secondary

MeasureTime frame
clarify the relationship of them in a phylogenetic context and to provide additional information on the molecular epidemiology of this parasite in our locality24 weeks
clarify the predominant clinical manifestation of each genotypes/subtypes of Cryptosporidium spp24 weeks
clarify the relationship between genotypes/subtypes of Cryptosporidium spp. and different risk factors.24 weeks

Countries

Egypt

Contacts

Primary ContactSalwa GA Omran, assistant lecturer
salwa.omran@med.sohag.edu.eg01011154173

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026